Allegheny Health Network Appoints Nipun Merchant as new Chair of Surgery and Chief Surgeon

Allegheny Health Network Welcomes Nipun Merchant as Chair of Surgery

In a significant move for the Allegheny Health Network (AHN), Dr. Nipun B. Merchant has been appointed as the Chair of the Department of Surgery and the first Surgeon-in-Chief. His new role is set to commence in February 2027, marking a pivotal moment in the network's surgical care evolution.

A Leadership Asset to AHN

Dr. Merchant comes to AHN with an illustrious background, having served at the University of Miami Health System and Sylvester Comprehensive Cancer Center. There, he held multiple esteemed positions, including Chief Surgical Officer and Executive Director of Perioperative Services. His extensive experience encompasses various areas of clinical care, scientific research, and health system operations, setting the stage for impactful leadership at AHN.

Commitment to Integrated Surgical Care

The establishment of the surgeon-in-chief position highlights AHN's dedication to cultivating a cohesive and integrated surgical care model across its network. During his tenure, Dr. Merchant aims to elevate the Department of Surgery's profile on a national scale, focusing on enhancing patient care, education, and research efforts. This commitment represents a significant investment in the department's future, fostering an environment conducive to exceptional surgical healthcare delivery.

Advancements in Oncology

Dr. Merchant is particularly renowned for his work in the field of surgical oncology, emphasizing gastrointestinal, hepatobiliary, and pancreatic cancers. He has dedicated his career to improving the diagnosis and treatment of these challenging forms of cancer. His research initiatives delve into the biology of pancreatic cancer, exploring tumor microenvironments and innovative therapeutic approaches designed to customize treatment and enhance patient outcomes.

While at the University of Miami, Dr. Merchant played a crucial role in developing one of the country’s leading multidisciplinary pancreatic cancer programs. With over 250 peer-reviewed publications to his name, he has seamlessly translated laboratory advancements into groundbreaking clinical trials, significantly benefiting gastrointestinal malignancy patients.

Educational Leadership and Future Aspirations

In addition to his clinical responsibilities, Dr. Merchant leads a National Cancer Institute-funded training program to prepare the next generation of surgeon-scientists. His leadership experience extends to numerous prestigious organizations, including the American College of Surgeons and the Society of Surgical Oncology.

Expressing his excitement about his new role, Dr. Merchant stated, “I am honored to join AHN at such a pivotal time in its growth. It presents an incredible opportunity to build on a strong clinical foundation and innovate across an integrated health system. I look forward to collaborating with the network’s professionals to cultivate a Department of Surgery where excellence in patient care, education, and discovery are harmonized.”

Thanking the Interim Leadership

Dr. Merchant’s appointment follows the interim leadership of Dr. David Bartlett, who has served as the Interim Chair of the Department of Surgery. Dr. Bartlett's guidance throughout this transitional phase was instrumental in maintaining the department's momentum, and his contributions are greatly appreciated by the AHN community.

About Allegheny Health Network

AHN is a comprehensive healthcare system serving Western Pennsylvania, with a network of hospitals, ambulatory surgery centers, and wellness pavilions. With around 27,000 employees and 3,000 physicians within its workforce, AHN is dedicated to delivering a full spectrum of advanced medical services, from primary care to specialized surgical interventions. More information about AHN and its services can be found at AHN.org.

With Dr. Merchant's leadership, AHN aims to not only enhance its surgical offerings but also redefine what surgical excellence means for the region's diverse patient population.